SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-619121
Filing Date
2016-06-10
Accepted
2016-06-10 16:33:37
Documents
7
Period of Report
2016-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d202559d8k.htm 8-K 17719
2 EX-1.1 d202559dex11.htm EX-1.1 183085
3 EX-5.1 d202559dex51.htm EX-5.1 6563
4 EX-99.1 d202559dex991.htm EX-99.1 7065
5 EX-99.2 d202559dex992.htm EX-99.2 7023
6 GRAPHIC g202559g37k51.jpg GRAPHIC 3731
7 GRAPHIC g202559g88x89.jpg GRAPHIC 3176
  Complete submission text file 0001193125-16-619121.txt   232711
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 161709013
SIC: 2834 Pharmaceutical Preparations